Novartis says 82 percent of leukemia patients in remission after CAR-T
BASEL, Switzerland: An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form… Read More
9 years ago
BASEL, Switzerland: An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form… Read More